The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)



Gene Review

E2F5  -  E2F transcription factor 5, p130-binding

Homo sapiens

Synonyms: E2F-5, Transcription factor E2F5
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of E2F5


High impact information on E2F5

  • However, in contrast to E2F-1, E2F-4 and E2F-5 fail to bind pRb in a two-hybrid assay [4].
  • These findings suggest that E2F-4 and E2F-5 may contribute to the regulation of early G1 events including the G0/G1 transition [4].
  • By using a specific E2F-5 antiserum, we found that under physiological conditions, E2F-5 interacts preferentially with p130 [5].
  • Indeed, E2F-5 is exported from the nucleus through leptomycin B-sensitive, CRM1-mediated transport, through a region corresponding to amino acid residues 130-154 [2].
  • Because E2F-5 is predominantly cytoplasmic in undifferentiated keratinocytes and in other intact cells, we also examined whether this protein is subjected to active nuclear export [2].

Biological context of E2F5

  • E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle [4].
  • This suggests that E2F5 behaves like a MYC-type cooperating oncogene in functional assays, prompting us to monitor potential amplifications of the E2F5 gene in primary human tumors [1].
  • The E2F4 and E2F5 proteins specifically associate with the Rb-related p130 protein in quiescent cells to repress transcription of various genes encoding proteins important for cell growth [6].
  • We have also demonstrated the presence of a strong transactivation domain at the carboxy terminus (273-346 amino acid residues) of E2F-5 protein [7].
  • Alterations at the transcriptional level were identified, namely, upregulation of JUN and E2F5 [8].

Anatomical context of E2F5

  • Moreover, they show a unique pattern of expression in synchronized human keratinocytes: E2F-4 and E2F-5 mRNA expression is maximal in mid-G1 phase before E2F-1 expression is detectable [4].
  • 5-kb E2F5 transcript was also detected in some tumors and tumor cell lines [1].
  • The distribution of E2F-5 mRNA among adult rat tissues and the temporal pattern of its expression during the cell cycle of vascular smooth muscle cells are distinctly different from that of E2F-1 [9].
  • We have previously shown that LAP2beta, an integral nuclear-envelope protein that contains the chromatin-binding LEM domain, was able to repress the transcriptional activity of the E2F5-DP3 heterodimer [10].
  • Novel genes expressed in adipocytes included E2F5 transcriptional factor and SMARC (SWI/SNF-related, matrix associated, actin-dependent regulator of chromatin) [11].

Associations of E2F5 with chemical compounds

  • In conclusion, these results indicated that the transcription factor E2F-5 was actively involved in the regulation of euxanthone-induced neurite outgrowth via PKC pathway [3].

Regulatory relationships of E2F5

  • We show that E2F5 can promote the formation of morphologically transformed foci in primary baby rat kidney cells (BRK) when it is overexpressed in the presence of its heterodimeric partner DP1 and activated RAS [1].
  • It was found that p53 specifically inhibited activated transcription by E2F-5 but not by E2F-1 [12].

Other interactions of E2F5

  • E2F-5, only in conjunction with DP1, promoted cell cycle progression [13].
  • We found that, consistent with a role for E2F5 in transcriptional repression, E2F5's binding partner p130, like Rb, could also actively repress transcription when directly bound to a target promoter [14].
  • The three genes showed ICN, albeit at variable incidence and levels of amplification, with the ICN of E2F5 occurring concomitantly with those of MOS and/or MYC in almost half of the cases [1].
  • Go6976, a protein kinase C (PKC) alpha/betaI inhibitor, was found to inhibit neuritogenesis and expression of E2F-5 in the euxanthone-treated BU-1 cells, while SH-6, the Akt/PKB inhibitor, had no inhibitory effect [3].
  • E2F-2 and E2F-5 were not detectable [15].

Analytical, diagnostic and therapeutic context of E2F5


  1. Human E2F5 gene is oncogenic in primary rodent cells and is amplified in human breast tumors. Polanowska, J., Le Cam, L., Orsetti, B., Vallés, H., Fabbrizio, E., Fajas, L., Taviaux, S., Theillet, C., Sardet, C. Genes Chromosomes Cancer (2000) [Pubmed]
  2. Active nuclear import and export pathways regulate E2F-5 subcellular localization. Apostolova, M.D., Ivanova, I.A., Dagnino, C., D'Souza, S.J., Dagnino, L. J. Biol. Chem. (2002) [Pubmed]
  3. Involvement of protein kinase C and E2F-5 in euxanthone-induced neurite differentiation of neuroblastoma. Ha, W.Y., Wu, P.K., Kok, T.W., Leung, K.W., Mak, N.K., Yue, P.Y., Ngai, S.M., Tsai, S.N., Wong, R.N. Int. J. Biochem. Cell Biol. (2006) [Pubmed]
  4. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Sardet, C., Vidal, M., Cobrinik, D., Geng, Y., Onufryk, C., Chen, A., Weinberg, R.A. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  5. E2F-5, a new E2F family member that interacts with p130 in vivo. Hijmans, E.M., Voorhoeve, P.M., Beijersbergen, R.L., van 't Veer, L.J., Bernards, R. Mol. Cell. Biol. (1995) [Pubmed]
  6. A mechanism of COOH-terminal binding protein-mediated repression. Meloni, A.R., Lai, C.H., Yao, T.P., Nevins, J.R. Mol. Cancer Res. (2005) [Pubmed]
  7. The molecular and functional characterization of E2F-5 transcription factor. Vaishnav, Y.N., Vaishnav, M.Y., Pant, V. Biochem. Biophys. Res. Commun. (1998) [Pubmed]
  8. Changes in apoptosis-related pathways in acute myelocytic leukemia. Casas, S., Ollila, J., Aventín, A., Vihinen, M., Sierra, J., Knuutila, S. Cancer Genet. Cytogenet. (2003) [Pubmed]
  9. Structural characterization and specificity of expression of E2F-5: a new member of the E2F family of transcription factors. Itoh, A., Levinson, S.F., Morita, T., Kourembanas, S., Brody, J.S., Mitsialis, S.A. Cell. Mol. Biol. Res. (1995) [Pubmed]
  10. The nuclear-envelope protein and transcriptional repressor LAP2beta interacts with HDAC3 at the nuclear periphery, and induces histone H4 deacetylation. Somech, R., Shaklai, S., Geller, O., Amariglio, N., Simon, A.J., Rechavi, G., Gal-Yam, E.N. J. Cell. Sci. (2005) [Pubmed]
  11. Gene expression profiling in human preadipocytes and adipocytes by microarray analysis. Urs, S., Smith, C., Campbell, B., Saxton, A.M., Taylor, J., Zhang, B., Snoddy, J., Jones Voy, B., Moustaid-Moussa, N. J. Nutr. (2004) [Pubmed]
  12. Differential regulation of E2F transcription factors by p53 tumor suppressor protein. Vaishnav, Y.N., Pant, V. DNA Cell Biol. (1999) [Pubmed]
  13. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells. Dirks, P.B., Rutka, J.T., Hubbard, S.L., Mondal, S., Hamel, P.A. Oncogene (1998) [Pubmed]
  14. Differential activities of E2F family members: unique functions in regulating transcription. Pierce, A.M., Schneider-Broussard, R., Philhower, J.L., Johnson, D.G. Mol. Carcinog. (1998) [Pubmed]
  15. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Strom, D.K., Cleveland, J.L., Chellappan, S., Nip, J., Hiebert, S.W. Cell Growth Differ. (1998) [Pubmed]
  16. Differentiation and injury-repair signals modulate the interaction of E2F and pRB proteins with novel target genes in keratinocytes. Chang, W.Y., Andrews, J., Carter, D.E., Dagnino, L. Cell Cycle (2006) [Pubmed]
WikiGenes - Universities